概括
渐进性系统性硬化症 (PSS) 可以引起明显的心肌病变,导致心律失常,心力衰竭和突然死亡. 这项研究证实PSS心肌病是一种重要的临床实体.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 病理学 病理学 病理学
背景情况:
- 在进展性全身性硬化症 (PSS) 中心肌病的存在和特征一直受到争论.
- 之前的研究并没有最终确定心脏参与PSS的患病率或临床影响.
研究的目的:
- 分析心肌病病的临床和病理特征在患有进展性全身性硬化症的患者.
- 确定PSS中心肌病变的患病率,功能意义和潜在原因.
- 调查心肌病理与PSS中的临床心脏表现之间的关系.
主要方法:
- 从52名尸体解剖后患有进展性全身性硬化症的患者的临床和病理数据的回顾性分析.
- 肌肉病理学检查心肌组织以识别和分级病变.
- 在患有重症,轻症和没有PSS心肌病变的患者之间比较临床心脏异常.
主要成果:
- 在23名患者中发现了明显的焦点心肌病变,从收缩带缩到纤维化.
- 没有发现心脏内冠状动脉的异常是这些病变的原因.
- 患有严重心肌压缩症的患者表现出明显更高的心室节律失常和导电障碍的频率.
- 严重的PSS心肌病与难以治疗的充血性心力衰竭,冠状动脉正常的胸痛和突然死亡有关.
结论:
- 心肌干扰在渐进性系统性硬化症中是一个独特的病理实体.
- 观察到的心肌病变可能是间歇性血管的结果,类似于心脏内雷诺现象.
- 心肌的渐进性系统性硬化会导致显著的心脏发病率和死亡率,包括心律失常,心力衰竭和突然死亡.
更多相关视频
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
